Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-17 Option Award |
2025-03-19 4:27 pm |
N/A 2035-03-17 |
RECURSION PHARMACEUTICALS INC. | RXRX | Sun Elaine D Director |
109,648 | $0 | 109,648 (Direct) |
View |
2024-05-23 Option Award |
2024-05-28 8:19 pm |
N/A 2031-05-22 |
DYNAVAX TECHNOLOGIES CORP | DVAX | Sun Elaine D Director |
27,857 | $0 | 46,607 (Direct) |
View |
2023-05-26 Option Award |
2023-05-31 5:34 pm |
N/A 2030-05-25 |
DYNAVAX TECHNOLOGIES CORP | DVAX | Sun Elaine D Director |
27,857 | $0 | 41,250 (Direct) |
View |
2022-05-26 Option Award |
2022-05-27 5:01 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | Sun Elaine D Director |
13,929 | $0 | 13,929 (Direct) |
View |
2021-12-10 Option Award |
2021-12-14 7:23 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | Sun Elaine D Director |
55,714 | $0 | 55,714 (Direct) |
View |
Ownership |
2021-12-14 5:04 pm |
N/A N/A |
DYNAVAX TECHNOLOGIES CORP | DVAX | Sun Elaine D Director |
0 | $0 | 0 (Direct) |
View |
2021-04-01 Tax Withholding |
2021-04-01 7:43 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer |
4,059 | $42.43 | 44,618 (Direct) |
View |
2021-04-01 Exercise |
2021-04-01 7:43 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer |
10,196 | $0 | 44,618 (Direct) |
View |
2021-03-02 Exercise |
2021-03-02 7:15 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer |
12,166 | $0 | 44,377 (Direct) |
View |
2021-03-02 Tax Withholding |
2021-03-02 7:15 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer |
4,285 | $45.01 | 44,377 (Direct) |
View |
2021-02-15 Option Award |
2021-02-17 5:03 pm |
2022-02-15 2031-02-15 |
HALOZYME THERAPEUTICS INC. | HALO | Sun Elaine D SVP, Chief Financial Officer |
40,540 | $0 | 40,540 (Direct) |
View |